SCHEMBL15445274

SCHEMBL15445274

C=CCCCCCCCC(=O)C(CCCCCCC=C)C(=O)OCC

nearest known ligand 0.47

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 4/20 0.47
LMNA P02545 2/20 0.47
MAPT P10636 4/20 0.44
CYP3A4 P08684 3/20 0.44
USP2 O75604 3/20 0.44
SMN1; SMN2 Q16637 2/20 0.44
HPGD P15428 1/20 0.44
ABCC4 O15439 1/20 0.44
RECQL P46063 1/20 0.42
L3MBTL1 Q9Y468 2/20 0.40
MAPK1 P28482 1/20 0.40
FAAH O00519 2/20 0.39
TSHR P16473 3/20 0.38
TDP1 Q9NUW8 2/20 0.38
ALOX15 P16050 1/20 0.38
HSD17B10 Q99714 1/20 0.38
KMT2A Q03164 2/20 0.37
MEN1 O00255 1/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7224713 0.90 MAPT (0.49) ALDH1A1LMNAMAPTCYP3A4USP2
SCHEMBL9453302 0.90 MAPT (0.49) ALDH1A1LMNAMAPTCYP3A4USP2
SCHEMBL7074449 0.90 MAPT (0.49) ALDH1A1LMNAMAPTCYP3A4USP2
SCHEMBL6067595 0.89 L3MBTL1 (0.47) ALDH1A1LMNAMAPTCYP3A4USP2
SCHEMBL5854304 0.87 ALDH1A1 (0.42) ALDH1A1LMNAMAPTCYP3A4USP2
SCHEMBL5855604 0.84 MAPT (0.38) ALDH1A1LMNAMAPTCYP3A4USP2
SCHEMBL1123650 0.83 CES2 (0.48)
SCHEMBL2717743 0.83 CES2 (0.48)
SCHEMBL2207325 0.83 L3MBTL1 (0.48) ALDH1A1LMNAMAPTCYP3A4USP2
SCHEMBL8342328 0.80 TDP1 (0.44) ALDH1A1LMNAMAPTCYP3A4USP2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 12 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-9346729-B2 Methods of converting mixtures of palmitoleic and oleic acid esters to high value products HELIAE DEVELOPMENT, LLC (US) 2016-05-24 US disclosed
US-9346729-B2 Methods of converting mixtures of palmitoleic and oleic acid esters to high value products HELIAE DEVELOPMENT, LLC (US) 2016-05-24 US disclosed
US-20150344401-A1 METHODS OF CONVERTING MIXTURES OF PALMITOLEIC AND OLEIC ACID ESTERS TO HIGH VALUE PRODUCTS HELIAE DEVELOPMENT LLC 2015-12-03 US disclosed
US-20150344401-A1 METHODS OF CONVERTING MIXTURES OF PALMITOLEIC AND OLEIC ACID ESTERS TO HIGH VALUE PRODUCTS HELIAE DEVELOPMENT LLC 2015-12-03 US disclosed
US-9126916-B2 Methods of converting mixtures of palmitoleic and oleic acid esters to high value products HELIAE DEVELOPMENT, LLC (US) 2015-09-08 US disclosed
US-9126916-B2 Methods of converting mixtures of palmitoleic and oleic acid esters to high value products HELIAE DEVELOPMENT, LLC (US) 2015-09-08 US disclosed
US-20150133693-A1 METHODS OF CONVERTING MIXTURES OF PALMITOLEIC AND OLEIC ACID ESTERS TO HIGH VALUE PRODUCTS HELIAE DEVELOPMENT, LLC (US) 2015-05-14 US disclosed
US-20150133693-A1 METHODS OF CONVERTING MIXTURES OF PALMITOLEIC AND OLEIC ACID ESTERS TO HIGH VALUE PRODUCTS HELIAE DEVELOPMENT, LLC (US) 2015-05-14 US disclosed
US-8642814-B1 Methods of converting mixtures of palmitoleic and oleic acid esters to high value products HELIAE DEVELOPMENT, LLC (US) 2014-02-04 US disclosed
US-8642814-B1 Methods of converting mixtures of palmitoleic and oleic acid esters to high value products HELIAE DEVELOPMENT, LLC (US) 2014-02-04 US disclosed
US-20140031592-A1 METHODS OF CONVERTING MIXTURES OF PALMITOLEIC AND OLEIC ACID ESTERS TO HIGH VALUE PRODUCTS HELIAE DEVELOPMENT, LLC (US) 2014-01-30 US disclosed
US-20140031592-A1 METHODS OF CONVERTING MIXTURES OF PALMITOLEIC AND OLEIC ACID ESTERS TO HIGH VALUE PRODUCTS HELIAE DEVELOPMENT, LLC (US) 2014-01-30 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20140031592-A1 METHODS OF CONVERTING MIXTURES OF PALMITOLEIC AND OLEIC ACID ESTERS TO HIGH VALUE PRODUCTS COASY, FASN, FADS1 ALDH1A1 2994/4885LMNA 1393/4885MAPT 3232/4885
US-20150133693-A1 METHODS OF CONVERTING MIXTURES OF PALMITOLEIC AND OLEIC ACID ESTERS TO HIGH VALUE PRODUCTS COASY, FASN, FADS1 ALDH1A1 2994/4885LMNA 1393/4885MAPT 3232/4885
US-20150344401-A1 METHODS OF CONVERTING MIXTURES OF PALMITOLEIC AND OLEIC ACID ESTERS TO HIGH VALUE PRODUCTS COASY, FASN, FADS1 ALDH1A1 2994/4885LMNA 1393/4885MAPT 3232/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.